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In Brief
 
Stem Cells and Mosaic Diseases
 
Two papers from the same laboratory
(Arin et al., page 645 and Cao et al.,
page 651), describe the use of an in-
ducible gene targeting strategy to de-
velop mouse models for serious hu-
man skin diseases. The work has
important implications for gene ther-
apy, and also helps to explain why
some genetic defects cause a mosaic
disease, while others do not. In mosa-
icism, genetically distinct populations
of cells arise from the same lineage in
a single tissue; the mechanistic differ-
ences between mosaic and nonmo-
saic genetic diseases are poorly un-
 
derstood.
 
Arin et al. developed an inducible
mouse model for epidermolytic hyper-
keratosis (EHK), an autosomal-domi-
nant skin blistering disorder caused by
mutations in keratin K1 or K10. When
a topical inducer is applied to patches
of skin on these mice, the activation of
a recombinase produces a local popu-
lation of mutant epidermal stem cells,
leading to persistent EHK lesions
characteristic of a mosaic form of the
disease. In this system, mutant and
wild-type stem cells can coexist in the
basal layer of the epidermis.
 
Cao et al. focused on the Dowling-
Meara variant of epidermolysis
bullosa (EBS-DM), an autosomal-
dominant blistering disease that does
not have a mosaic form. In Cao et al.’s
 
inducible mouse model for this dis-
ease, topical application of an inducer
results in EBS phenotypes in the
treated areas, but the induced blisters
heal rapidly as nonphenotypic stem
cells migrate into the wound. Cao et
al. speculate that the mutations re-
sponsible for EBS place stem cells at a
selective disadvantage relative to
wild-type stem cells, precluding the
development of a mosaic disease and
suggesting that substantially different
gene therapy strategies will be re-
quired to treat EBS and EHK.
 
A Novel Sec1 Gene
in Cytokinesis
 
Assaad et al. (page 531) positionally
 
cloned 
 
KEULE
 
, a gene required for
cytokinesis in 
 
Arabidopsis thaliana
 
,
and determined that it encodes a Sec1
protein that interacts with a vesicle-
trafficking syntaxin. Sec1 proteins and
syntaxins have been shown to interact
during vesicle trafficking in a variety
of systems, but the new work suggests
a novel linkage between this interac-
tion and the cell cycle.
After cloning the gene and identify-
ing it as a putative Sec1 homologue,
Assaad et al. determined that
KEULE exists in both soluble and
membrane-associated forms, and that
it binds to the cytokinesis-specific syn-
taxin KNOLLE in vitro, indicating
that it is also functionally homologous
to a Sec1 superfamily protein. When
wild-type plants are transformed with
 
a 
 
KEULE
 
–GFP gene fusion, cytoki-
nesis-defective mutant sectors are ob-
served in all somatic tissues, indicating
that KEULE is required for cytokine-
sis throughout the plant life cycle. Da-
tabase searches of the 
 
Arabidopsis
 
 ge-
 
nome revealed two highly conserved
homologues of 
 
KEULE
 
. Because
Sec1 proteins are key regulators of
vesicle trafficking, Assaad et al. pro-
pose that KEULE may act through
KNOLLE to integrate cell cycle sig-
nals and transduce them to the cytoki-
netic vesicle fusion machinery.
 
How the Extracellular Matrix 
Regulates Anoikis
 
Detachment from the extracellular
matrix induces apoptosis in endothe-
lial cells, but the molecular mecha-
nisms controlling this biologically im-
portant phenomenon, called anoikis,
have remained poorly understood.
Beginning on page 633, Aoudjit and
Vuori report that matrix attachment
regulates Fas-mediated apoptosis by
modulating the expression levels of
the death receptor Fas and the
caspase-8 antagonist c-Flip. The find-
ings have important implications both
for developing new antiangiogenic tu-
mor therapies and for understanding
the pathogenesis of vascular diseases.
 
Reasoning that matrix attachment
might affect endothelial cell survival
by regulating Fas-mediated killing,
Aoudjit and Vuori examined whether
anoikis is linked to activation of the
Fas pathway. They found that even
when the Fas receptor is expressed on
the cell surface, adherent endothelial
cells resist Fas-mediated apoptosis.
Matrix attachment modulates apopto-
sis at two levels, controlling the avail-
ability of Fas by regulating the recep-
tor’s expression, and controlling
receptor-induced activation of cas-
pase-8 by regulating the expression of
c-Flip. Detachment from the extracel- 
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lular matrix enhances Fas expression
and inhibits c-Flip expression, activat-
ing the Fas/Fas-L death pathway and
leading to apoptosis. Because of the
importance of caspase-8 in other re-
ceptor-induced apoptotic pathways,
Aoudjit and Vuori suggest that matrix
attachment may regulate apoptosis in
a similar fashion in other cell types.
 
Dystroglycans in Acetylcholine 
Receptor Clustering
 
Using both a chimeric mouse model
and isolated myotubes generated
from embryonic stem cells, Jacobson
et al. (page 435) have gained signifi-
cant new insights into the role of dys-
troglycans in the organization of the
neuromuscular junction (NMJ). The
dystroglycans comprise two subunits
of a complex of dystrophin associated
proteins (DAP), linking the cytoskel-
eton in a myofiber to its basement
membrane in a myofiber. Though the
DAP complex was thought to be in-
volved in the formation of nerve–
muscle synapses, the mechanisms reg-
ulating this process have remained
poorly understood. In the new work,
Jacobson et al. examined the clus-
tering of acetylcholine receptors
(AChR) and basement membrane as-
sembly. Muscle from dystroglycan-
deficient mice, and myotubes gener-
ated from dystroglycan null ES cells,
both develop AChR clusters that are
larger, less dense, and less stable than
the AChR clusters on their wild-type
counterparts. Dystroglycan deficiency
also disrupts the association of lami-
nin, perlecan, and acetylcholines-
terase (AChE) to the AChR clusters,
but does not affect the localization of
rapsyn or agrin to the clusters.
Jacobson et al. previously have
shown that dystroglycans cluster un-
der the nerve during synapse forma-
tion, and they now propose that this
clustering is essential for the proper
assembly of the postsynaptic special-
ization. In this model, dystroglycans
 
stabilize AChR clusters through their
interactions with laminin extracellu-
larly and utrophin intracellularly,
while AChE is assembled into the syn-
aptic basement membrane through its
binding to perlecan.
 
Hsc70 Regulates Clathrin-
coated Vesicle Disassembly
 
Newmyer and Schmid (page 607)
have demonstrated that the heat
shock cognate protein hsc70 not only
regulates coat disassembly in the
clathrin coated vesicle (CCV) cycle,
but also appears to have a broader
role in modulating clathrin dynamics
throughout the CCV cycle. In addi-
tion to confirming another activity of
hsc70, the work paves the way for a
 
more complete understanding of the
mechanisms controlling cytosolic
clathrin maintenance and the forma-
tion of coated vesicles.
Previous studies have implicated
hsc70 as a CCV cycle component, but
in the new work, Newmyer and
Schmid directly examined the effect of
hsc70 mutations on clathrin dynamics
in vivo. When ATPase-deficient forms
of hsc70 are overexpressed in cultured
cells, CCV uncoating is inhibited and
unassembled cytosolic clathrin shifts to
an assembled pool, indicating that
hsc70 is involved in regulating clathrin
disassembly. Since the assembled coat
proteins accumulate in the absence of
cargo receptors, Newmyer and Schmid
suggest that this pool may represent
misassembled empty clathrin cages.
Overexpressing the mutant forms of
hsc70 also blocks the recycling of the
transferrin receptor. Based on their re-
sults, Newmyer and Schmid propose
that hsc70 may act in endosomal traf-
ficking as a chaperone for cytosolic
clathrin. In this model, hsc70 might
regulate multiple steps in the CCV cy-
cle by preventing clathrin from inap-
propriately self-assembling.
 
Alan W. Dove, 350 E. Willow Grove Ave. #406, Phila-
delphia, PA 19118. E-mail: alanwdove@earthlink.net